Horizon makes management appointments
This article was originally published in Scrip
The US biopharmaceutical company Horizon Therapeutics has named Amy Grahn vice-president of clinical operations and Iain Duncan senior vice-president of operations. Ms Grahn was most recently vice-president of clinical operations at MedGenesis Therapeutix. Mr Duncan was a co-founder of Corus Pharma, which was bought by Gilead Sciences, and was most recently Corus's vice-president of operations.